NCT01238978 - Phase 4 Study in the Elderly Patients With T2DM | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Type 2 Diabetes MellitusElderly

Interventions

DRUG

Vildagliptin

DRUG

"Usual Care"

Trial Locations (15)

Novartis Investigative Site, Caen

Novartis Investigative Site, Brest

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Tours

Novartis Investigative Site, Saint-Jean-de-la-Ruelle

Novartis Investigative Site, Armentières

Novartis Investigative Site, Creil

Novartis Investigative Site, Pau

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Vénissieux

Novartis Investigative Site #2, Paris

Novartis Investigative Site, Paris

Novartis Investigative Site, Versailles

Novartis Investigative Site, Strasbourg

Novartis Investigative Site #2, Vénissieux